Design and Synthesis of Bis 1-Chloromethyl-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI)-Pyrrole Polyamide Conjugates

Organic Letters

Volumn 4, Issue 11, 2002, Pages 1851-1854

  Kumar, Rohtash ^a   Lown, J William ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLENE; ALDEHYDE; ALKYLATING AGENT; BENZALDEHYDE DERIVATIVE; BIS 1 CHLOROMETHYL 5 HYDROXY 1,2 DIHYDRO 3H BENZ(E)INDOLE(SECO CBI) PYRROLE POLYAMIDE; BIS-1-CHLOROMETHYL-5-HYDROXY-1,2- DIHYDRO-3H-BENZ(E)INDOLE(SECO-CBI)-PYRROLE POLYAMIDE; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; INDOLE DERIVATIVE; PHENYLACETYLENE; PYRROLE DERIVATIVE;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG DESIGN; DRUG SCREENING; HUMAN; KINETICS; MOUSE; SYNTHESIS;

ACETYLENE; ALDEHYDES; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BENZALDEHYDES; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDICATORS AND REAGENTS; INDOLES; KINETICS; MICE; PYRROLES; TUMOR CELLS, CULTURED;

EID: 0037198774     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol020047k     Document Type: Article

References (34)

1. Boger, D. L.; Johnson, D. S. Angew. Chem., Int. Ed. Engl. 1996, 35, 1439.
2. Boger, D. L.; Boyce, C. W.; Garbaccio, R. M.; Goldberg, J. Chem. Rev. 1997, 97, 787.
3. Boger, D. L.; Johnson, D. S. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3642.
4. Boger, D. L. Acc. Chem. Res. 1995, 28, 20.
5. Boger, D. L. Chemtracts: Org. Chem. 1991, 4, 329.
6. Warpehoski, M. A.; Hurley, L. H. Chem. Res. Toxicol. 1988, 1, 315.
7. Hurley, L. H.; Needham-VanDevanter, D. R. Acc. Chem. Res. 1986, 19, 230.
8. Warpehoski, M. A. In Advances in DNA Sequence Specific Agents; Hurley, L. H., Ed.; JAI: Greenwich, CT, 1992; Vol. 1, p 315.
9. Aristoff, P. A. In Advances in Medicinal Chemistry; Maryanoff, B. E., Ed.; JAI: Greenwich, CT, 1993; Vol. 2, p 67.
10. Warpehoski, M. A.; McGovren, P.; Mitchell, M. A. In Molecular Basis of Specificity in Nucleic Acid-Drug Interactions; Pullman, B., Jortner, J., Eds.; Kluwer: Dordrecht, The Netherlands, 1990; p 531.
11. Reynolds, V. L.; Molineux, I.; Kaplan, D. J.; Swenson, D. H.; Hurley, L. H. Biochemistry 1985, 24, 6228.
12. Hurley, L. H.; Reynolds, V. L.; Swenson, D. H.; Petzold, G. L.; Scahill, T. A. Science 1984, 226, 843.
13. (a) Boger, D. L.; Colemon, R. S. J. Am. Chem. Soc. 1988, 110, 4196.
14. (b) Lin, C. H.; Sun, D.; Hurley, L. H. Chem. Res. Toxicol. 1991, 4, 21.
15. (a) Boger, D. L.; Ishizaki, T.; Wysocki, R. J.; Munk, S. A.; Kitos, P. A.; Suntornwat, O. J. Am. Chem. Soc. 1989, 111, 6461.
16. (b) Boger, D. L.; Ishizaki, T. J. Org. Chem. 1990, 55, 5823.
17. (c) Aristoff, P. A.; Johnson, P. D. J. Org. Chem. 1992, 57, 6234.
18. (a) Lown, J. W. Synthesis of Sequence-specific Agents: Lexitropsins. In Molecular Aspects of Anticancer Drug-DNA Interactions; Neidle, S., Waring, M., Eds.; CRC Press: Boca Raton, FL, 1993; Vol. 1, p 322.
19. (b) Dervan, P. B. Science 1986, 232, 464.
20. (c) Trauger, J. W.; Baird, E. E.; Dervan, P. B. Angew. Chem., Int. Ed. 1998, 37, 1421.
21. (d) Mrksich, M.; Parks, M. E.; Dervan, P. B. J. Am. Chem. Soc. 1994, 116, 7983.
22. (a) Fregeau, N. L.; Wang, Y.; Pon, R. T.; Wylie, W. A.; Lown, J. W. J. Am. Chem. Soc. 1995, 117, 8917.
23. (b) Iida, H.; Lown, J. W. Recent Res. Dev. Synth. Org. Chem. 1998, 1, 17.
24. (a) Jia, G.; Iida, H.; Lown, J. W. Hetrocycl. Commun. 1998, 4, 557.
25. (b) Jia, G.; Iida, H.; Lown, J. W. Chem. Commun. 1999, 119.
26. (c) Jia, G.; Iida, H.; Lown, J. W. Synth. Lett. 2000, 5, 603.
27. (a) Mitchell, M. A.; Johnson, P. D.; Williams, M. G.; Aristoff, P. A. J. Am. Chem. Soc. 1989, 111, 6428.
28. (b) Mitchell, M. A.; Kelly, R. C.; Wicniensky, N. A.; Hatzenbuhler, N. T.; Williams, M. G.; Petzold, G. L.; Slihgtom, J. L.; Siemieniak, D. R. J. Am. Chem. Soc. 1991, 113, 8994.
29. (a) Jia, G.; Iida, H.; Lown, J. W. Hetrocycl. Commun. 1999, 5, 467.
30. (b) Jia, G.; Lown, J. W. Bioorg. Med. Chem. 2000, 8, 1607.
31. (a) Lown, J. W.; Krowicki, K. J. Org. Chem. 1985, 50, 3774.
32. (b) Zhao, R.; Lown, J. W. Heterocycles 1995, 41, 337.
33. +).
34. +).